ArticleBMC clinical pathology2014

alphaB-crystallin is a marker of aggressive breast cancer behavior but does not independently predict for patient outcome: a combined analysis of two randomized studies.

Triantafyllia Koletsa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.